DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2
about
Hepatitis C virus infection protein networkInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue virusesHepatitis C virus proteinsHigh-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoproteinScavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IPromoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.Uukuniemi Virus as a Tick-Borne Virus ModelDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Tetraspanins in viral infections: a fundamental role in viral biology?Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and InfectionCharacterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesEvaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleHepatitis C Virus Entry Depends on Clathrin-Mediated EndocytosisIdentification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingDiverse CD81 Proteins Support Hepatitis C Virus InfectionExpression of DC-SIGN and DC-SIGNR on Human Sinusoidal EndotheliumHepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissectionVirological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemiaCD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus InfectionEssential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral PropagationHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationReplication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope ProteinsSerum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 DependentCD81-Dependent Binding of Hepatitis C Virus E1E2 HeterodimersCD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human HepatocytesIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesHepatitis C Virus entry: the early steps in the viral replication cycleMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineAmphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryThe impact of hepatitis C virus entry on viral tropismC-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particlesHybrid, silica-coated, Janus-like plasmonic-magnetic nanoparticles
P2860
Q24311906-24B56AD5-BFF4-44FD-A44E-FF1F8A797695Q24519072-7F711BEA-167F-4AE7-9315-4BCCB3B40E78Q24536024-2E3959D3-AED0-4E02-82A2-7C5F99F5F57CQ24563969-762C090C-2D29-4E87-9541-C2213A5C71B9Q24595951-034CF840-36C6-4423-ABBE-28E12FB65604Q24672232-74EED24B-5B32-40D5-955A-0E66E2C3F53CQ24673797-F37353A8-9838-4896-95B4-F2178271B83CQ24676039-7E18A360-AD42-42B5-96DD-BA2A20110E58Q25256653-11E92554-0548-4EB0-9567-CBC9BA3BEF53Q26700151-A6907C19-6294-4ACF-B32E-7E72405156CDQ27010312-BE6010F5-1E12-47E2-817C-3BD50C3DBE74Q27469468-B10BDAB1-0B8A-41C9-A995-BCF5EED3EE5DQ27469844-6371551D-286C-4ABD-B41E-A4C8F4D0AE1EQ27470936-46074712-696A-4E48-BFED-C75F2330982CQ27472672-4F0A4AC0-3F5F-472B-BB32-56874E6CADAAQ27472768-43BE9F04-BD09-429F-974D-93672E38AF21Q27472821-1C3CA0A4-7CEC-4FE3-BEEC-A1D28AD92B4AQ27473226-D60C58AA-0F08-44A2-BD4D-46F27C7E640FQ27473287-E00EDDFC-227E-4508-B4D2-F089DDDCE0F3Q27473290-E0606919-4435-46A0-AF76-7752C9ACD5BFQ27477468-E35589A8-7520-4C17-BED7-9C0F558A255CQ27477625-BD8094A5-F83C-4221-B636-E6C456C94726Q27477777-7A6C5B76-BF50-4FE0-93AC-455132E71226Q27478121-6C1BE65E-3294-40CC-8467-21FAC7EC5A0CQ27478129-94F165BC-AEA6-4D87-A874-FF30F795B36DQ27480351-29D003C5-4F29-4CD0-97E4-F28DD6A6C90FQ27480927-30F48690-2C6F-4739-9091-EDAD5848DA77Q27481012-3A872E32-96D3-45BB-93C8-7012173622E7Q27481021-0BAF16C9-5232-4300-A2CA-49F161820878Q27485298-14D1FC35-D218-470F-971B-E1C6AE06BDEAQ27485659-B8FF03C2-1CA3-466F-96DF-38AFED31CC5DQ27486789-0CA050A6-1E34-4403-A8DA-77F26354D170Q27487399-0F984EC3-593F-447D-82F5-B1D2A02AC9CFQ27489242-6798CCE7-E69F-4B56-ADB0-50B2ABCDC99AQ27489898-3C559D09-8C07-4556-BB06-B90DA8834211Q27490526-7FE78F72-F3DE-47BB-8831-49F5613FAC35Q27490785-F18ECBCF-5866-4E13-8BA0-90DA90A8A420Q27693297-16717A7C-B0D8-40C3-A7E1-2212D35F9CA2Q28263849-C3408D39-091A-40C6-87A2-C5D6447CA373Q28291943-1CAC03EB-B52F-476E-A684-C2E23E4BD23B
P2860
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@ast
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en-gb
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@nl
type
label
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@ast
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en-gb
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@nl
prefLabel
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@ast
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en-gb
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
DC-SIGN and L-SIGN are high af ...... atitis C virus glycoprotein E2
@en
P2093
Agnès de Lacroix de Lavalette
Corinne Houles
Frank Fieschi
Hugues Lortat-Jacob
Isabelle Staropoli
Jean-Louis Virelizier
Ralf Altmeyer
Steven Foung
P2860
P304
P3181
P356
10.1074/JBC.M301284200
P407
P577
2003-05-30T00:00:00Z